Evidence map›Paper›PMID 31048679›Full record

ArticleTranslational psychiatry2019

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.

Daniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, Susana García-Cerro, Natalia Rodríguez, Mara Parellada, Jeronimo Saiz-Ruiz, Manolo J Cuesta, Patricia Gassó, Amalia Lafuente and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Translational psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Daniel BolocDepartment of Medicine, University of Barcelona, Barcelona, Spain.
Anna GortatDepartment of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
Jia Qi Cheng-ZhangDepartment of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
Susana García-CerroDepartment of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
Natalia RodríguezDepartment of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
Mara ParelladaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.
Jeronimo Saiz-RuizCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.
Manolo J CuestaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.
Patricia GassóDepartment of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
Amalia LafuenteDepartment of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain.
Miquel BernardoDepartment of Medicine, University of Barcelona, Barcelona, Spain. bernardo@clinic.ub.es.
Sergi MasDepartment of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain. sergimash@ub.edu.ORCID http://orcid.org/0000-0003-3336-6298

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the funding sources (FEDER-Unión Europea) was not previously acknowledged in this Article. This study was supported by the Spanish Ministry of Health, Instituto de Salud Carlos III (FIS, Fondo de Investigacion Sanitaria PI13/00812, PI16/0122) and FEDER-Unión Europea.

Identifiers

PMID31048679
PMCPMC6497654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.